Overview

Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The objectives of the study are to assess the systemic exposure, safety and efficacy of three concentrations of OMS201 in subjects undergoing retrograde ureteroscopic removal of upper urinary tract stones.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Omeros Corporation